Page last updated: 2024-08-21

nicotinamide mononucleotide and Cardiac Diseases

nicotinamide mononucleotide has been researched along with Cardiac Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, B; Li, J; Lin, Q; Liu, N; Liu, Q; Tu, T; Wu, K; Xiao, Y; Xu, W; Zhang, B; Zuo, W1

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and Cardiac Diseases

ArticleYear
Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation.
    Life sciences, 2021, Jun-01, Volume: 274

    Topics: Acetylation; Animals; Cardiotonic Agents; Fibrosis; Heart Diseases; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Nicotinamide Mononucleotide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Smad3 Protein

2021